CCN2 and chronic kidney disease: Pentoxifylline, a nonspecific phosphodiesterase inhibitor, attenuates tubulointerstitial fibrosis in CKD animal model (unilateral ureteral obstruction [UUO]) by interfering with the transcription of SMAD3/4 to suppresses CTGF [86].